FdaApplication
ANDA 211031
Identifiers
- fda_app_no: ANDA211031
Properties
| Property | Value |
|---|---|
| applicant_name | BRECKENRIDGE PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2019-02-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EXEMESTANE | EXEMESTANE | 25MG | TABLET;ORAL |
1 product